From a TTO’s standpoint: Finding the good match in asset transactions

Edition

From a TTO’s standpoint: Finding the good match in asset transactions

How are TTO’s evaluating the suitability and sustainability when out-licensing? To what extent are they assessing whether the licensees will have the know-how, vision and resources to develop the asset in an effective manner?

Richard Reschen

Associate Director, Business Development & Licensing
United Kingdom
MSD

Thomas Tradler

Head of Business Development and Patent Management
Germany
Fraunhofer Institute for Cell Therapy and Immunology

Holger Neecke

Head of Technology Transfer Office
Italy
IFOM, the FIRC Institute for Molecular Oncology

Chris Shelley

Partner
United Kingdom
Penningtons Manches LLP
Scroll to Top
  • No products in the cart.